Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 30, 2016
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma
Katja Behling, William F Maguire, José Carlos López Puebla, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties
M S Malamas, J Sredy, C Moxham, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 23, 2010
Paradoxical glomerular filtration of carbon nanotubes
Alessandro Ruggiero, Carlos H Villa, Evan Bander, et al.
Genes & Development
|
June 19, 2007
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization
Daniel J Nolan, Alessia Ciarrocchi, Albert S Mellick, et al.
Plos One
|
March 8, 2007
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization
Jaspreet Singh Jaggi, Erik Henke, Surya V Seshan, et al.
Science Translational Medicine
|
March 25, 2016
Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury
Simone Alidori, Nima Akhavein, Daniel L J Thorek, et al.
Cancer Research
|
March 31, 2001
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)
A M Ballangrud, W H Yang, D E Charlton, et al.
Oncotarget
|
October 15, 2017
<i>In vivo</i> immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
Dmitry Pankov, Ludvig Sjöström, Teja Kalidindi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 24, 1999
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia
G Sgouros, A M Ballangrud, J G Jurcic, et al.
Plos One
|
September 20, 2007
PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice
Michael R McDevitt, Debjit Chattopadhyay, Jaspreet S Jaggi, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 30, 2016
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma
Katja Behling, William F Maguire, José Carlos López Puebla, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties
M S Malamas, J Sredy, C Moxham, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 23, 2010
Paradoxical glomerular filtration of carbon nanotubes
Alessandro Ruggiero, Carlos H Villa, Evan Bander, et al.
Genes & Development
|
June 19, 2007
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization
Daniel J Nolan, Alessia Ciarrocchi, Albert S Mellick, et al.
Plos One
|
March 8, 2007
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization
Jaspreet Singh Jaggi, Erik Henke, Surya V Seshan, et al.
Science Translational Medicine
|
March 25, 2016
Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury
Simone Alidori, Nima Akhavein, Daniel L J Thorek, et al.
Cancer Research
|
March 31, 2001
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)
A M Ballangrud, W H Yang, D E Charlton, et al.
Oncotarget
|
October 15, 2017
<i>In vivo</i> immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
Dmitry Pankov, Ludvig Sjöström, Teja Kalidindi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 24, 1999
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia
G Sgouros, A M Ballangrud, J G Jurcic, et al.
Plos One
|
September 20, 2007
PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice
Michael R McDevitt, Debjit Chattopadhyay, Jaspreet S Jaggi, et al.
Page
of 12